XML 29 R2.htm IDEA: XBRL DOCUMENT
v3.23.1

Pay vs Performance Disclosure Unit_pure in Millions | 1 Months Ended | 9 Months Ended | 12 Months Ended
--- | --- | --- | ---
Jan. 31, 2020 USD ($) | Dec. 31, 2020 USD ($) | Dec. 31, 2022 USD ($) | Dec. 31, 2021 USD ($) | Dec. 31, 2020 USD ($)
Pay vs Performance Disclosure [Table] |  |  |  |  |
Pay vs Performance [Table Text Block] |  |  | Pay Versus Performance Disclosure As required by the Dodd-Frank Act and Item 402(v) of Regulation S-K, the Pay versus Performance disclosure that follows provides information about the relationship between Compensation Actually Paid, or CAP, to our Principal Executive Officer, or PEO, and Non-PEO NEOs and certain financial performance measures of the company. See the Compensation Discussion and Analysis within this proxy statement for further information concerning the company’s variable pay-for-performance philosophy and how the company aligns executive compensation with company performance.
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | Value of initial fixed $100 Investment based on: |  |  |  |  |  |  |
Year |  | Summary Compensation Table Total for PEO (Blanchard) |  |  | Summary Compensation Table Total for Other PEO (Darling) |  |  | Compensation Actually Paid to PEO (Blanchard) |  |  | Compensation Actually Paid to Other PEO (Darling) |  |  | Average Summary Compensation Table Total for non-PEO NEOs |  |  | Average Compensation Actually Paid to non-PEO NEOs |  |  | Total Shareholder Return |  |  | Peer Total Shareholder Return |  |  | Net Income ($mm) |  |  | Revenue ($mm) |
|  |  | (a) |  |  |  | (b) |  |  |  | (a) |  |  |  | (b) |  |  |  | (c) |  |  |  | (c) |  |  |  | (d) |  |  |  | (d) |  |  |  | (e) |  |  |  | (e) |
2022 |  | $ | 5,940,722 |  |  |  | N/A |  |  | $ | 3,599,763 |  |  |  | N/A |  |  | $ | 1,739,011 |  |  | $ | 1,406,419 |  |  | $ | 57 |  |  | $ | 111 |  |  | ($ | 15 | ) |  | $ | 156 |
2021 |  | $ | 4,202,608 |  |  |  | N/A |  |  | $ | 1,818,313 |  |  |  | N/A |  |  | $ | 1,234,846 |  |  | $ | 1,051,797 |  |  | $ | 69 |  |  | $ | 125 |  |  | $ | 4 |  |  | $ | 148 |
2020 |  | $ | 10,029,434 |  |  | $ | 288,753 |  |  | $ | 10,513,388 |  |  | ($ | 7,088,313 | ) |  | $ | 1,411,154 |  |  | $ | 772,039 |  |  | $ | 87 |  |  | $ | 126 |  |  | ($ | 24 | ) |  | $ | 130 |
(a) | Dr. Blanchard served as interim CEO for part of 2020 and was appointed President and CEO in April 2020.
(b) | Mr. Darling , CEO at the beginning of 2020, passed away unexpectedly in January 2020. All of Mr. Darling’s unvested equity was forfeited upon his death.
(c) | NEOs in 2022 include Messrs. Levitz and Colleran, NEOs in 2021 include Messrs. Levitz, Colleran, Thomas Finnerty and James Loerop. Mr. Loerop, the company’s EVP, Business Development and Strategic Planning, resigned in January 2022. Mr. Finnerty, the company’s EVP, Human Resources, retired in March 2022. NEOs in 2020 include Messrs. Levitz, Colleran, Finnerty, Loerop and Sylvia Cheung. Ms. Cheung, the company’s CFO, resigned in August 2020. Mr. Colleran joined the company as EVP, General Counsel and Secretary in March 2020, and Mr. Levitz joined company as EVP, CFO and Treasurer in August 2020.
(d) | Shareholder return is based on $100 investment at the beginning of 2020. Peer shareholder return is based on the NASDAQ Biotechnology Index.
(e) | Net Income and Revenue are as reported in the company’s Annual Report on Form 10-K for each fiscal year referenced.
Company Selected Measure Name |  |  | Revenue |  |
Named Executive Officers, Footnote [Text Block] |  |  |
(c) | NEOs in 2022 include Messrs. Levitz and Colleran, NEOs in 2021 include Messrs. Levitz, Colleran, Thomas Finnerty and James Loerop. Mr. Loerop, the company’s EVP, Business Development and Strategic Planning, resigned in January 2022. Mr. Finnerty, the company’s EVP, Human Resources, retired in March 2022. NEOs in 2020 include Messrs. Levitz, Colleran, Finnerty, Loerop and Sylvia Cheung. Ms. Cheung, the company’s CFO, resigned in August 2020. Mr. Colleran joined the company as EVP, General Counsel and Secretary in March 2020, and Mr. Levitz joined company as EVP, CFO and Treasurer in August 2020.
Peer Group Issuers, Footnote [Text Block] |  |  | Shareholder return is based on $100 investment at the beginning of 2020. Peer shareholder return is based on the NASDAQ Biotechnology Index. |  |
Adjustment To PEO Compensation, Footnote [Text Block] |  |  | The following table sets forth a reconciliation from the summary compensation table (SCT) to compensation actually paid (CAP) to our PEO and to our average non-PEO NEO each year.
|  | PEO (Blanchard) |  |  | PEO (Darling) |  |  | Average NEO |
|  | 2022 |  |  | 2021 |  |  | 2020 |  |  | 2020 |  |  | 2022 |  |  | 2021 |  |  | 2020 |
SCT Total Compensation |  | $ | 5,940,722 |  |  | $ | 4,202,608 |  |  | $ | 10,029,434 |  |  | $ | 288,753 |  |  | $ | 1,739,011 |  |  | $ | 1,234,846 |  |  | $ | 1,411,154 |
SUBTRACT Grant Fair Value of Equity Awards Made During Year (a) |  | ($ | 4,630,341 | ) |  | ($ | 2,942,637 | ) |  | ($ | 8,994,889 | ) |  | $ | 0 |  |  | ($ | 1,051,440 | ) |  | ($ | 658,333 | ) |  | ($ | 962,952 | )
ADD Year End Fair Value of Equity Awards Made During Year (b) |  | $ | 5,294,178 |  |  | $ | 3,254,974 |  |  | $ | 9,337,528 |  |  | $ | 0 |  |  | $ | 1,205,238 |  |  | $ | 728,209 |  |  | $ | 668,806 |
ADD Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards (c) |  | ($ | 1,016,462 | ) |  | ($ | 2,470,476 | ) |  | $ | 0 |  |  | $ | 0 |  |  | ($ | 274,828 | ) |  | ($ | 189,171 | ) |  | ($ | 64,142 | )
ADD Year over Year Change in Fair Value of Equity Awards Granted in Prior Year that Vested in the Year (d) |  | ($ | 1,988,334 | ) |  | ($ | 226,155 | ) |  | $ | 0 |  |  | ($ | 18,351 | ) |  | ($ | 211,562 | ) |  | ($ | 63,754 | ) |  | ($ | 83,186 | )
62
|  | PEO (Blanchard) |  |  | PEO (Darling) |  |  | Average NEO |
|  | 2022 |  |  | 2021 |  |  | 2020 |  |  | 2020 |  |  | 2022 |  |  | 2021 |  |  | 2020 |
ADD Fair Value at Vesting of Equity Awards Made During Year That Also Vested During Year (e) |  | $ | 0 |  |  | $ | 0 |  |  | $ | 141,315 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 0 |
SUBTRACT Fair Value at the End of the Prior Year of Equity Awards that Were Forfeited During Year (f) |  | $ | 0 |  |  | $ | 0 |  |  | $ | 0 |  |  | ($ | 7,358,716 | ) |  | $ | 0 |  |  | $ | 0 |  |  | ($ | 197,641 | )
Total Adjustments Related to Equity Awards |  | ($ | 2,340,959 | ) |  | ($ | 2,384,295 | ) |  | $ | 483,954 |  |  | ($ | 7,377,066 | ) |  | ($ | 332,592 | ) |  | ($ | 183,048 | ) |  | ($ | 639,115 | )
Compensation Actually Paid Total |  | $ | 3,599,763 |  |  | $ | 1,818,313 |  |  | $ | 10,513,388 |  |  | ($ | 7,088,313 | ) |  | $ | 1,406,419 |  |  | $ | 1,051,797 |  |  | $ | 772,039 |
(a) | Represents the grant date fair value of equity-based awards made during the fiscal year.
(b) | Represents the year-end fair value of equity awards that were made during the fiscal year.
(c) | Represents the change in fair value during the fiscal year of equity-based awards granted in prior fiscal years that were still unvested as of year-end.
(d) | Represents the change in fair value during the fiscal year of equity-based awards granted in prior fiscal years that vested during the current fiscal year.
(e) | Represents the fair value on the vesting date of equity-based awards that vested in the same year as granted. In 2020, Dr. Blanchard received a grant of RSUs for her service as interim Chief Executive Officer between February and April 2020, which RSUs fully vested upon her permanent appointment as President and CEO in April 2020.
(f) | Represents the prior year-end fair value of equity awards that were forfeited by other PEOs who terminated during the year. Mr. Darling passed away unexpectedly in early 2020, and unvested equity awards were forfeited upon his death.. Ms. Cheung resigned in August 2020 and all unvested equity awards were forfeited upon her resignation.
Non-PEO NEO Average Total Compensation Amount |  |  | $ 1,739,011 | $ 1,234,846 | $ 1,411,154
Non-PEO NEO Average Compensation Actually Paid Amount |  |  | $ 1,406,419 | 1,051,797 | 772,039
Adjustment to Non-PEO NEO Compensation Footnote [Text Block] |  |  | The following table sets forth a reconciliation from the summary compensation table (SCT) to compensation actually paid (CAP) to our PEO and to our average non-PEO NEO each year.
|  | PEO (Blanchard) |  |  | PEO (Darling) |  |  | Average NEO |
|  | 2022 |  |  | 2021 |  |  | 2020 |  |  | 2020 |  |  | 2022 |  |  | 2021 |  |  | 2020 |
SCT Total Compensation |  | $ | 5,940,722 |  |  | $ | 4,202,608 |  |  | $ | 10,029,434 |  |  | $ | 288,753 |  |  | $ | 1,739,011 |  |  | $ | 1,234,846 |  |  | $ | 1,411,154 |
SUBTRACT Grant Fair Value of Equity Awards Made During Year (a) |  | ($ | 4,630,341 | ) |  | ($ | 2,942,637 | ) |  | ($ | 8,994,889 | ) |  | $ | 0 |  |  | ($ | 1,051,440 | ) |  | ($ | 658,333 | ) |  | ($ | 962,952 | )
ADD Year End Fair Value of Equity Awards Made During Year (b) |  | $ | 5,294,178 |  |  | $ | 3,254,974 |  |  | $ | 9,337,528 |  |  | $ | 0 |  |  | $ | 1,205,238 |  |  | $ | 728,209 |  |  | $ | 668,806 |
ADD Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards (c) |  | ($ | 1,016,462 | ) |  | ($ | 2,470,476 | ) |  | $ | 0 |  |  | $ | 0 |  |  | ($ | 274,828 | ) |  | ($ | 189,171 | ) |  | ($ | 64,142 | )
ADD Year over Year Change in Fair Value of Equity Awards Granted in Prior Year that Vested in the Year (d) |  | ($ | 1,988,334 | ) |  | ($ | 226,155 | ) |  | $ | 0 |  |  | ($ | 18,351 | ) |  | ($ | 211,562 | ) |  | ($ | 63,754 | ) |  | ($ | 83,186 | )
62
|  | PEO (Blanchard) |  |  | PEO (Darling) |  |  | Average NEO |
|  | 2022 |  |  | 2021 |  |  | 2020 |  |  | 2020 |  |  | 2022 |  |  | 2021 |  |  | 2020 |
ADD Fair Value at Vesting of Equity Awards Made During Year That Also Vested During Year (e) |  | $ | 0 |  |  | $ | 0 |  |  | $ | 141,315 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 0 |  |  | $ | 0 |
SUBTRACT Fair Value at the End of the Prior Year of Equity Awards that Were Forfeited During Year (f) |  | $ | 0 |  |  | $ | 0 |  |  | $ | 0 |  |  | ($ | 7,358,716 | ) |  | $ | 0 |  |  | $ | 0 |  |  | ($ | 197,641 | )
Total Adjustments Related to Equity Awards |  | ($ | 2,340,959 | ) |  | ($ | 2,384,295 | ) |  | $ | 483,954 |  |  | ($ | 7,377,066 | ) |  | ($ | 332,592 | ) |  | ($ | 183,048 | ) |  | ($ | 639,115 | )
Compensation Actually Paid Total |  | $ | 3,599,763 |  |  | $ | 1,818,313 |  |  | $ | 10,513,388 |  |  | ($ | 7,088,313 | ) |  | $ | 1,406,419 |  |  | $ | 1,051,797 |  |  | $ | 772,039 |
(a) | Represents the grant date fair value of equity-based awards made during the fiscal year.
(b) | Represents the year-end fair value of equity awards that were made during the fiscal year.
(c) | Represents the change in fair value during the fiscal year of equity-based awards granted in prior fiscal years that were still unvested as of year-end.
(d) | Represents the change in fair value during the fiscal year of equity-based awards granted in prior fiscal years that vested during the current fiscal year.
(e) | Represents the fair value on the vesting date of equity-based awards that vested in the same year as granted. In 2020, Dr. Blanchard received a grant of RSUs for her service as interim Chief Executive Officer between February and April 2020, which RSUs fully vested upon her permanent appointment as President and CEO in April 2020.
(f) | Represents the prior year-end fair value of equity awards that were forfeited by other PEOs who terminated during the year. Mr. Darling passed away unexpectedly in early 2020, and unvested equity awards were forfeited upon his death.. Ms. Cheung resigned in August 2020 and all unvested equity awards were forfeited upon her resignation.
Compensation Actually Paid vs. Total Shareholder Return [Text Block] |  |  |  |  |
Compensation Actually Paid vs. Net Income [Text Block] |  |  |  |  |
Compensation Actually Paid vs. Company Selected Measure [Text Block] |  |  |  |  |
Total Shareholder Return Vs Peer Group [Text Block] |  |  |  |  |
Tabular List [Table Text Block] |  |  | The following table sets forth what we consider to be the most important financial performance measures in how CAP was linked to company performance during 2022. Key Financial Measures Revenues Gross Margin Adjusted EBITDA |  |
Total Shareholder Return Amount |  |  | $ 57 | 69 | 87
Peer Group Total Shareholder Return Amount |  |  | 111 | 125 | 126
Net Income (Loss) |  |  | $ (15,000,000) | $ 4,000,000 | $ (24,000,000)
Company Selected Measure Amount |  |  | 156 | 148 | 130
PEO Name |  |  | Dr. Blanchard | Dr. Blanchard |
Measure [Axis]: 1 |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Measure Name |  |  | Revenues |  |
Non-GAAP Measure Description [Text Block] |  |  | Net Income and Revenue are as reported in the company’s Annual Report on Form 10-K for each fiscal year referenced. |  |
Measure [Axis]: 2 |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Measure Name |  |  | Gross Margin |  |
Measure [Axis]: 3 |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Measure Name |  |  | Adjusted EBITDA |  |
Dr. Blanchard [Member] |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
PEO Total Compensation Amount |  | $ 10,029,434 | $ 5,940,722 | $ 4,202,608 | $ 10,029,434
PEO Actually Paid Compensation Amount |  | $ 10,513,388 | 3,599,763 | 1,818,313 | 10,513,388
PEO Name |  | Dr. Blanchard |  |  |
Mr. Darling [Member] |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
PEO Total Compensation Amount | $ 288,753 |  |  |  | 288,753
PEO Actually Paid Compensation Amount | $ (7,088,313) |  |  |  | (7,088,313)
PEO Name | Mr. Darling |  |  |  |
PEO [Member] | Dr. Blanchard [Member] | Grant Fair Value of Equity Awards Made During Year [Member] |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount |  |  | (4,630,341) | (2,942,637) | (8,994,889)
PEO [Member] | Dr. Blanchard [Member] | Year End Fair Value of Equity Awards Made During Year [Member] |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount |  |  | 5,294,178 | 3,254,974 | 9,337,528
PEO [Member] | Dr. Blanchard [Member] | Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards [Member] |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount |  |  | (1,016,462) | (2,470,476) | 0
PEO [Member] | Dr. Blanchard [Member] | Year over Year Change in Fair Value of Equity Awards Granted in Prior Year that Vested in the Year [Member] |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount |  |  | (1,988,334) | (226,155) | 0
PEO [Member] | Dr. Blanchard [Member] | Fair Value at Vesting of Equity Awards Made During Year That Also Vested During Year [Member] |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount |  |  | 0 | 0 | 141,315
PEO [Member] | Dr. Blanchard [Member] | Fair Value at the End of the Prior Year of Equity Awards that Were Forfeited During Year [Member] |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount |  |  | 0 | 0 | 0
PEO [Member] | Dr. Blanchard [Member] | Adjustments Related to Equity Awards [Member] |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount |  |  | (2,340,959) | (2,384,295) | 483,954
PEO [Member] | Mr. Darling [Member] | Grant Fair Value of Equity Awards Made During Year [Member] |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount |  |  |  |  | 0
PEO [Member] | Mr. Darling [Member] | Year End Fair Value of Equity Awards Made During Year [Member] |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount |  |  |  |  | 0
PEO [Member] | Mr. Darling [Member] | Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards [Member] |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount |  |  |  |  | 0
PEO [Member] | Mr. Darling [Member] | Year over Year Change in Fair Value of Equity Awards Granted in Prior Year that Vested in the Year [Member] |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount |  |  |  |  | (18,351)
PEO [Member] | Mr. Darling [Member] | Fair Value at Vesting of Equity Awards Made During Year That Also Vested During Year [Member] |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount |  |  |  |  | 0
PEO [Member] | Mr. Darling [Member] | Fair Value at the End of the Prior Year of Equity Awards that Were Forfeited During Year [Member] |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount |  |  |  |  | (7,358,716)
PEO [Member] | Mr. Darling [Member] | Adjustments Related to Equity Awards [Member] |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount |  |  |  |  | (7,377,066)
Non-PEO NEO [Member] | Grant Fair Value of Equity Awards Made During Year [Member] |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount |  |  | (1,051,440) | (658,333) | (962,952)
Non-PEO NEO [Member] | Year End Fair Value of Equity Awards Made During Year [Member] |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount |  |  | 1,205,238 | 728,209 | 668,806
Non-PEO NEO [Member] | Year over Year Change in Fair Value of Outstanding and Unvested Equity Awards [Member] |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount |  |  | (274,828) | (189,171) | (64,142)
Non-PEO NEO [Member] | Year over Year Change in Fair Value of Equity Awards Granted in Prior Year that Vested in the Year [Member] |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount |  |  | (211,562) | (63,754) | (83,186)
Non-PEO NEO [Member] | Fair Value at Vesting of Equity Awards Made During Year That Also Vested During Year [Member] |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount |  |  | 0 | 0 | 0
Non-PEO NEO [Member] | Fair Value at the End of the Prior Year of Equity Awards that Were Forfeited During Year [Member] |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount |  |  | 0 | 0 | (197,641)
Non-PEO NEO [Member] | Adjustments Related to Equity Awards [Member] |  |  |  |  |
Pay vs Performance Disclosure [Table] |  |  |  |  |
Adjustment to Compensation Amount |  |  | $ (332,592) | $ (183,048) | $ (639,115)

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToNonPeoNeoCompFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_AdjToPeoCompFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_CoSelectedMeasureAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_CoSelectedMeasureName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph iii + Details
Name: | ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph ii + Details
Name: | ecd_CompActuallyPaidVsNetIncomeTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph i + Details
Name: | ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_MeasureName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_NamedExecutiveOfficersFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph vi + Details
Name: | ecd_NonGaapMeasureDescriptionTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iii + Details
Name: | ecd_NonPeoNeoAvgCompActuallyPaidAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph ii + Details
Name: | ecd_NonPeoNeoAvgTotalCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_PeerGroupIssuersFnTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_PeerGroupTotalShareholderRtnAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iii + Details
Name: | ecd_PeoActuallyPaidCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 3 + Details
Name: | ecd_PeoName
Namespace Prefix: | ecd_
Data Type: | xbrli:normalizedStringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph ii + Details
Name: | ecd_PeoTotalCompAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 1 + Details
Name: | ecd_PvpTable
Namespace Prefix: | ecd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 1 + Details
Name: | ecd_PvpTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 6 + Details
Name: | ecd_TabularListTableTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 2 -Subparagraph iv + Details
Name: | ecd_TotalShareholderRtnAmt
Namespace Prefix: | ecd_
Data Type: | xbrli:monetaryItemType
Balance Type: | na
Period Type: | duration

X
- References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-K -Number 229 -Section 402 -Subsection v -Paragraph 5 -Subparagraph iv + Details
Name: | ecd_TotalShareholderRtnVsPeerGroupTextBlock
Namespace Prefix: | ecd_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04(22)) -URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 4 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 220 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04(18)) -URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 815 -SubTopic 40 -Section 65 -Paragraph 1 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 50 -Paragraph 6 -URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756 Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03(20)) -URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227 Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b)(2) -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(i)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 9 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iv)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756 Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(4)(ii)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -Subparagraph (f) -URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 3 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 60B -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 8 -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794 Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 1A -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580 Reference 25: http://www.xbrl.org/2003/role/exampleRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599 Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 11 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794 Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 250 -SubTopic 10 -Section 50 -Paragraph 11 -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794 Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 7 -URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760 Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 1B -Subparagraph (a) -URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580 Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 31: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1A -Subparagraph (SX 210.13-01(a)(5)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756 Reference 32: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(B)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756 Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section S99 -Paragraph 1B -Subparagraph (SX 210.13-02(a)(4)(iii)(A)) -URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756 Reference 34: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 Reference 35: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 32 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599 + Details
Name: | us-gaap_NetIncomeLoss
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | ecd_MeasureAxis=1
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=2
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_MeasureAxis=3
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=anik_BlanchardMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_IndividualAxis=anik_DarlingMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_ExecutiveCategoryAxis=ecd_PeoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=anik_GrantFairValueOfEquityAwardsMadeDuringYearMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=anik_YearEndFairValueOfEquityAwardsMadeDuringYearMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=anik_YearOverYearChangeInFairValueOfOutstandingAndUnvestedEquityAwardsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=anik_YearOverYearChangeInFairValueOfEquityAwardsGrantedInPriorYearThatVestedInTheYearMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=anik_FairValueAtVestingOfEquityAwardsMadeDuringYearThatAlsoVestedDuringYearMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=anik_FairValueAtTheEndOfThePriorYearOfEquityAwardsThatWereForfeitedDuringYearMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_AdjToCompAxis=anik_AdjustmentsRelatedToEquityAwardsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |